Treatment of Graves' Disease and Associated Ophthalmopathy With the Anti-Cd20 Monoclonal Antibody Rituximab: An Open Study

European Journal of Endocrinology - United Kingdom
doi 10.1530/eje.1.02325
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Targeted Biological Therapies for Graves’ Disease and Thyroid-Associated Ophthalmopathy. Focus on B-Cell Depletion With Rituximab

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2010English

Phase I Study of Chimeric Anti-Cd20 Monoclonal Antibody in Chinese Patients With CD20-positive Non-Hodgkin’s Lymphoma

Chinese Journal of Cancer Research
Cancer ResearchOncology
2016English

The Evolving Role of Selenium in the Treatment of Graves' Disease and Ophthalmopathy

Journal of Thyroid Research
EndocrinologyMetabolismDiabetes
2012English

Current and Future Treatments for Graves’ Disease and Graves’ Ophthalmopathy

Hormone and Metabolic Research
BiochemistryEndocrinologyClinical BiochemistryMedicineMetabolismDiabetes
2018English

Treatment of Atopic Dermatitis With Tralokinumab, an Anti–IL-13 Monoclonal Antibody

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Characterization of Novel Murine Anti-Cd20 Monoclonal Antibodies and Their Comparison to 2B8 and C2B8 (Rituximab)

International Journal of Oncology
Cancer ResearchOncology
2007English

Anti-Lymphoma Efficacy Comparison of Anti-Cd20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2015English

Inhibition of Increased Circulating TFH Cell by Anti-Cd20 Monoclonal Antibody in Patients With Type 1 Diabetes

PLoS ONE
Multidisciplinary
2013English

Clinical Impact of B-Cell Depletion With the Anti-Cd20 Antibody Rituximab in Chronic Fatigue Syndrome: A Preliminary Case Series

BMC Neurology
MedicineNeurology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy